GROUPE BERKEM |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.57 EUR | -9.77% |
|
+11.35% | -48.69% |
| Apr. 30 | Groupe Berkem Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Feb. 06 | Givaudan: agreement signed with Berkem | CF |
| Sales 2023 | 52.4M 56.22M | Sales 2024 * | 59.27M 63.58M | Capitalization | 27.75M 29.77M |
|---|---|---|---|---|---|
| Net income 2023 * | 2M 2.15M | Net income 2024 * | 1M 1.07M | EV / Sales 2023 | 1.03 x |
| Net Debt 2023 * | 16.43M 17.63M | Net Debt 2024 * | 21.57M 23.14M | EV / Sales 2024 * | 0.83 x |
| P/E ratio 2023 * |
11.8
x | P/E ratio 2024 * |
15.2
x | Employees | 234 |
| Yield 2023 * |
3.82% | Yield 2024 * |
1.91% | Free-Float | 31.92% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 day | -9.77% | ||
| 1 week | +11.35% | ||
| Current month | -18.23% | ||
| 1 month | -15.59% | ||
| 3 months | -49.35% | ||
| 6 months | -4.85% | ||
| Current year | -48.69% |
1 week
1.39
1.87
1 month
1.351.94
Current year
1.353.70
1 year
1.186.10
3 years
1.1810.50
5 years
1.1810.50
10 years
1.1810.50
| Managers | Title | Age | Since |
|---|---|---|---|
Olivier Fahy
CEO | Chief Executive Officer | 58 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Olivier Fahy
CEO | Chief Executive Officer | 58 | - |
Fahy Stanislas
BRD | Director/Board Member | - | 21-03-07 |
Lambert Thierry
BRD | Director/Board Member | - | 21-03-07 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-02 | 1.57 | -9.77% | 50,582 |
| 24-04-30 | 1.74 | +21.68% | 142,982 |
| 24-04-29 | 1.43 | -0.69% | 18,825 |
| 24-04-26 | 1.44 | +2.86% | 9,682 |
| 24-04-25 | 1.4 | 0.00% | 10,037 |
Real-time Euronext Paris, May 02, 2024 at 11:35 am EDT
More quotes
Berkem Group is a chemical group organized around 4 business units:
- production of active ingredients: from the extraction of plant materials. In addition, the group offers freeze-drying services for the food, cosmetics, nutraceutical and pharmaceutical industries, etc.;
- formulation of solutions for the preservation and protection of materials: in particular wood materials;
- distribution of solutions for the treatment, machining and protection of wood materials;
- manufacture of alkyd resins: for the paint, construction, wood treatment and ink industries.
At the end of 2021, the company has 3 production sites located in France.
France accounts for 79% of net sales.
Sector
Pharmaceuticals
Calendar
2024-06-24
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.57
EUR
Average target price
5.233
EUR
Spread / Average Target
+233.33%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -48.69% | 32.84M | |
| +29.68% | 699B | |
| +25.07% | 571B | |
| -4.35% | 364B | |
| +17.65% | 326B | |
| +3.77% | 286B | |
| +14.68% | 236B | |
| +4.71% | 198B | |
| -12.43% | 194B | |
| -3.79% | 154B |
- Stock Market
- Equities
- ALKEM Stock
